Catherine Serke Williams

Array ( [id] => 6535353 [patent_doc_number] => 20100204142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THE PEPTIDE PHPFHLFVY (RENIN INHIBITOR) AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677356 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34144 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204142.pdf [firstpage_image] =>[orig_patent_app_number] => 12677356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6534401 [patent_doc_number] => 20100204090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677547 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33819 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204090.pdf [firstpage_image] =>[orig_patent_app_number] => 12677547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6506919 [patent_doc_number] => 20100210559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'TRAP-14 AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677749 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33993 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210559.pdf [firstpage_image] =>[orig_patent_app_number] => 12677749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535651 [patent_doc_number] => 20100204156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF THYMOPENTIN AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677514 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204156.pdf [firstpage_image] =>[orig_patent_app_number] => 12677514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535327 [patent_doc_number] => 20100204140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677302 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33614 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204140.pdf [firstpage_image] =>[orig_patent_app_number] => 12677302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535663 [patent_doc_number] => 20100204157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677566 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34082 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204157.pdf [firstpage_image] =>[orig_patent_app_number] => 12677566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514344 [patent_doc_number] => 20100216724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'USE OF FIBRONECTIN FRAGMENT (196-203 ) AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677553 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34235 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216724.pdf [firstpage_image] =>[orig_patent_app_number] => 12677553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535338 [patent_doc_number] => 20100204141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'USE OF BPP-B AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677317 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33918 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204141.pdf [firstpage_image] =>[orig_patent_app_number] => 12677317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285367 [patent_doc_number] => 20090099042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Reverse Two-Hybrid System for Identification of Interaction Domains' [patent_app_type] => utility [patent_app_number] => 12/206562 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099042.pdf [firstpage_image] =>[orig_patent_app_number] => 12206562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11191562 [patent_doc_number] => 09422363 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-23 [patent_title] => 'Synthetic apolipoprotein E mimicking polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 12/675089 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 22552 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10186826 [patent_doc_number] => 09216235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Photoactivated crosslinking of a protein or peptide' [patent_app_type] => utility [patent_app_number] => 12/673400 [patent_app_country] => US [patent_app_date] => 2008-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16965 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102580 [patent_doc_number] => 20110166073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'ANTI-HYPERTENSIVE AGENT' [patent_app_type] => utility [patent_app_number] => 12/671953 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7047 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166073.pdf [firstpage_image] =>[orig_patent_app_number] => 12671953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5962329 [patent_doc_number] => 20110147218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT' [patent_app_type] => utility [patent_app_number] => 12/670533 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3602 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20110147218.pdf [firstpage_image] =>[orig_patent_app_number] => 12670533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324152 [patent_doc_number] => 20090062142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Methods for enhancing bacterial cell display of proteins and peptides' [patent_app_type] => utility [patent_app_number] => 12/220448 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19928 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062142.pdf [firstpage_image] =>[orig_patent_app_number] => 12220448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711922 [patent_doc_number] => 08093028 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Engineered glycosyltransferases with expanded substrate specificity' [patent_app_type] => utility [patent_app_number] => 12/179531 [patent_app_country] => US [patent_app_date] => 2008-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19036 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093028.pdf [firstpage_image] =>[orig_patent_app_number] => 12179531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10038232 [patent_doc_number] => 09078927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Self-assembling complex for targeting chemical agents to cells' [patent_app_type] => utility [patent_app_number] => 12/667436 [patent_app_country] => US [patent_app_date] => 2008-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 11667 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12667436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296153 [patent_doc_number] => 20100240597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'METHODS OF DELIVERY OF MOLECULES TO CELLS USING A RICIN SUBUNIT AND COMPOSITIONS RELATING TO SAME' [patent_app_type] => utility [patent_app_number] => 12/664342 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 42870 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240597.pdf [firstpage_image] =>[orig_patent_app_number] => 12664342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373675 [patent_doc_number] => 20090311236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Therapeutic Peptide Compositions And Methods Of Making And Using Same' [patent_app_type] => utility [patent_app_number] => 12/137236 [patent_app_country] => US [patent_app_date] => 2008-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 17592 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311236.pdf [firstpage_image] =>[orig_patent_app_number] => 12137236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552296 [patent_doc_number] => 20090286282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Method for Producing Antibody Fragments' [patent_app_type] => utility [patent_app_number] => 12/134645 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11097 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286282.pdf [firstpage_image] =>[orig_patent_app_number] => 12134645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6387631 [patent_doc_number] => 20100317587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'INJECTABLE BONE REGENERATION GEL CONTAINING BONE FORMATION ENHANCING PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/663399 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3406 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317587.pdf [firstpage_image] =>[orig_patent_app_number] => 12663399 [rel_patent_id] =>[rel_patent_doc_number] =>)